Mangoceuticals, Inc. MGRX
We take great care to ensure that the data presented and summarized in this overview for MANGOCEUTICALS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MGRX
Top Purchases
Top Sells
About MGRX
Insider Transactions at MGRX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2025
|
Eugene M Johnston CFO |
SELL
Open market or private sale
|
Direct |
3,333
-2.7%
|
$3,333
$1.17 P/Share
|
|
Dec 09
2025
|
Eugene M Johnston CFO |
SELL
Open market or private sale
|
Direct |
5,000
-3.9%
|
$5,000
$1.2 P/Share
|
|
Dec 05
2025
|
Eugene M Johnston CFO |
SELL
Open market or private sale
|
Direct |
10,000
-7.23%
|
$10,000
$1.13 P/Share
|
|
Nov 19
2025
|
Alex P. Hamilton Director |
SELL
Open market or private sale
|
Direct |
125,000
-97.4%
|
$125,000
$1.22 P/Share
|
|
Sep 09
2025
|
Kenny Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+42.25%
|
-
|
|
Sep 09
2025
|
Alex P. Hamilton Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+44.12%
|
-
|
|
Sep 09
2025
|
Lorraine Pamela D'Alessio Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+42.25%
|
-
|
|
Sep 09
2025
|
Eugene M Johnston CFO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+41.96%
|
-
|
|
Apr 10
2025
|
Jacob D. Cohen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+50.0%
|
-
|
|
Apr 10
2025
|
Lorraine Pamela D'Alessio Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+40.54%
|
-
|
|
Apr 10
2025
|
Antonios Isaac President |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+50.0%
|
-
|
|
Apr 10
2025
|
Alex P. Hamilton Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+46.87%
|
-
|
|
Apr 10
2025
|
Kenny Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+40.54%
|
-
|
|
Nov 11
2024
|
Eugene M Johnston CFO |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+39.47%
|
-
|
|
Aug 26
2024
|
Jacob D. Cohen Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
800,000
+8.1%
|
-
|
|
Aug 26
2024
|
Jacob D. Cohen Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
800,000
-100.0%
|
-
|
|
Jun 26
2024
|
Alex P. Hamilton Director |
SELL
Open market or private sale
|
Direct |
108,426
-68.44%
|
$0
$0.32 P/Share
|
|
Jun 25
2024
|
Alex P. Hamilton Director |
SELL
Open market or private sale
|
Direct |
16,574
-9.47%
|
$0
$0.31 P/Share
|
|
Jun 03
2024
|
Lorraine Pamela D'Alessio Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+36.36%
|
-
|
|
Jun 03
2024
|
Jacob D. Cohen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
935K
Shares
From
6
Insiders
| Grant, award, or other acquisition | 935K shares |
|---|
Sell / Disposition
143K
Shares
From
2
Insiders
| Open market or private sale | 143K shares |
|---|